Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |